Benefits include: Stable blood sugar without dangerous spikes and crashes Reduced food cravings and improved appetite control Enhanced fat burning and metabolic efficiency Better stress resilience and hormonal balance Safety and Monitoring: Your Wellness, Our Priority The safety profile of tirzepatide is generally acceptable, similar to GLP-1 RAs
During the first year, between 60% to 80% of patients with type 2 diabetes experience major improvement or remission
Food and Drug Administration (FDA) is tightening oversight of imports of GLP-1 drug ingredients amid concerns that many of the items may be adulterated and pose a safety risk
Retatrutide is an investigational injectable triple receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors to reduce appetite, improve blood glucose control, and increase energy expenditure
As a cash-pay practice, we offer transparent pricing with no insurance billing
Found operates in most US states, though access to compounded GLP-1s, which are not FDA approved, depends on local regulations and availability
